Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel
R Banerjee, Y Biru, CE Cole, B Faiman, S Midha… - Blood cancer …, 2024 - nature.com
Many studies have documented racial, socioeconomic, geographic, and other disparities for
United States (US) patients with multiple myeloma pertaining to diagnosis and frontline …
United States (US) patients with multiple myeloma pertaining to diagnosis and frontline …
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study
Multiple myeloma (MM) is a complex hematological malignancy of clonal plasma cells
driven by alterations to the chromosomal material leading to uncontrolled proliferation in the …
driven by alterations to the chromosomal material leading to uncontrolled proliferation in the …
Disparities in time to treatment with oral antimyeloma medications
This retrospective cohort study used Taussig Cancer Center's Myeloma Patient Registry to
identify adults with multiple myeloma diagnosed between January 2017-December 2021 …
identify adults with multiple myeloma diagnosed between January 2017-December 2021 …